Organon, the human health care business unit of Akzo Nobel and Sareum Holdings plc, the specialist structure-based drug discovery and services business, today announced a collaborative research agreement.
Organon, the human health care business unit of Akzo Nobel and Sareum Holdings plc, the specialist structure-based drug discovery and services business, today announced a collaborative research agreement.
